Bootstrap
Trading Non Stop
ar | bg | cz | dk | de | el | en | es | fi | fr | in | hu | id | it | ja | kr | nl | no | pl | br | ro | ru | sk | sv | th | tr | uk | ur | vn | zh | zh-tw |

What could affect the price of INJ?

Injective’s price is currently influenced by a mix of positive technology updates and broader market challenges.

  1. EVM Mainnet Launch – Native Ethereum compatibility encourages more DeFi projects to join (Positive)
  2. Staked ETF Filings – Potential SEC approval could bring in institutional investors (Speculative)
  3. Buyback Program – Offers a 10% yield and reduces token supply through burns (Mixed)

Deep Dive

1. EVM Mainnet & MultiVM Expansion (Positive Impact)

Overview: On November 11, Injective launched its native Ethereum Virtual Machine (EVM), allowing developers who build on Ethereum to easily create decentralized apps (dApps) on Injective without changing their code. More than 40 projects, including deBridge and Anchorage, have already joined the upgraded network. There are also plans to add Solana Virtual Machine support. The network now processes blocks every 0.64 seconds, with transaction fees as low as $0.00008.

What this means: By connecting Ethereum developers with Injective’s liquidity (the amount of assets available for trading), Injective could see increased activity in decentralized finance (DeFi). Similar upgrades in other networks, like Avalanche in 2021, have led to price increases when usage grows. Keep an eye on the total value locked (TVL) in dApps and the number of transactions after this launch (The Block).

2. Staked INJ ETF Regulatory Path (Speculative Impact)

Overview: In July 2025, Cboe BZX and Canary Capital filed for approval of a staked INJ exchange-traded fund (ETF). This would be the first ETF that includes staking rewards tied to a Layer-1 blockchain token like INJ. The U.S. Securities and Exchange Commission (SEC) is expected to make a decision after the upcoming election.

What this means: If approved, this ETF would officially recognize INJ as a regulated investment, potentially attracting large institutional investors. However, delays or rejection—common with altcoin ETFs—could lead to price drops. The ETF’s promise of a 10% staking yield adds both opportunity and risk (CoinDesk).

3. Buyback Mechanics & Tokenomics (Mixed Impact)

Overview: Injective’s buyback program uses 60% of fees from decentralized apps to buy and burn INJ tokens, reducing supply. Participants in the program earn a 10% yield. Since July 2025, about 6.6 million INJ tokens (worth roughly $49 million) have been burned. Despite this, INJ’s price remains about 50% below its peak in 2024.

What this means: While the token burn creates deflationary pressure (which can support prices), the program’s success depends on continued fee income. Recent price declines (down 17% in the past month) suggest some doubt about whether this can be sustained. Watch monthly burn rates and revenue from new dApps for signs of growth (Injective Blog).

Conclusion

Injective’s new EVM support and the potential ETF approval are strong positive factors. However, broader economic concerns (crypto Fear Index at 25) and challenges in execution remain risks. For traders, the key question is: Will the increase in dApp activity driven by EVM integration outweigh the market’s cautious sentiment? Follow developer adoption rates and SEC Chair Gensler’s comments on ETFs for guidance.

{{technical_analysis_coin_candle_chart}}


What are people saying about INJ?

Injective’s community is balancing hopes for ETF approval with concerns about price drops and token burns. Here’s what’s trending:

  1. ETF excitement grows as Canary Capital files for a staked INJ ETF (@ali_charts)
  2. Bearish chart signals suggest a possible 30% price drop if support at $8 breaks
  3. Token burns increase as more activity on the Injective platform reduces supply
  4. EVM upgrade buzz drives some analysts to predict prices could hit $30

Deep Dive

1. @EdgenTech: Institutional ETF filing boosts optimism

"21Shares has filed for a U.S. INJ ETF – if approved, it could bring a liquidity boost similar to Bitcoin’s ETF launch."
– @EdgenTech (2.9K followers · 7.9K impressions · 2025-10-22 19:03 UTC)
View original post
What this means: Approval of an ETF would be a big win for Injective, signaling institutional trust and opening the door for more investment. This comes as Injective expands its real-world asset tokenization.

2. @ali_charts: Chart patterns warn of potential price drop

"INJ has started a new downward move – $8.30 is next if trading volume stays high."
– @ali_charts (162K followers · 7.7M impressions · 2025-08-30 20:01 UTC)
View original post
What this means: Technical indicators suggest a possible short-term decline. If the price falls below $8.07 (currently $7.49), it could trigger more selling. However, the Relative Strength Index (RSI) shows the token might be oversold, which could limit the drop.

3. @kylobtc: Token burns reduce supply amid growing use

"Another $INJ burn is underway – fees are now used in monthly token buybacks and burns."
– @kylobtc (38K followers · 2.5M impressions · 2025-09-21 04:00 UTC)
View original post
What this means: This is a positive sign for INJ holders. Since 2024, over 6.6 million INJ tokens (worth about $49.4 million) have been burned, reducing supply. The current inflation rate is negative 3.2% annually, meaning the total supply is shrinking.

4. [@Crypto Rand](https://x.com/Crypto Rand): EVM upgrade sparks $30 price predictions

"INJ is on track for $30 – it’s becoming a top 10 blockchain by revenue with over 36,000 code updates."
– @Crypto Rand (Unlisted followers · 2025-07-28 12:15 UTC)
View original post
What this means: The upcoming EVM (Ethereum Virtual Machine) upgrade will make it easier for Ethereum developers to build on Injective. With the current price at $14.46, it’s still 67% below its all-time high of $52, leaving room for growth.

Conclusion

The outlook for Injective (INJ) is mixed. Positive factors like ETF filings, token burns, and the EVM upgrade compete with bearish chart signals. The market’s Fear & Greed Index at 25/100 shows caution, but INJ’s 17% gain over the past week highlights resilience. Key price levels to watch are between $8 and $15. Breaking above $15, especially with ETF progress, could support a move toward $30. On the other hand, failure to hold support might lead to retesting lows from earlier in 2025. The upcoming SEC decision on staked crypto ETFs, expected in the first quarter of 2026, will be a major factor to watch.


What is the latest news about INJ?

Injective is making big moves with new technology upgrades and growing its community. Here’s what’s new:

  1. Native EVM Launch (November 11, 2025) – Injective now supports Ethereum-based apps directly on its blockchain, sharing liquidity with the Cosmos network.
  2. Binance Rewards Campaign (November 12, 2025) – Users can earn INJ tokens by trading or creating content during a special promotion.
  3. Price Approaching $10 (November 11, 2025) – Technical indicators suggest the price might rise despite recent ups and downs.

In-Depth Look

1. Native EVM Launch (November 11, 2025)

What happened:
Injective added a new feature called the Ethereum Virtual Machine (EVM) to its blockchain, which is built on Cosmos technology. This means developers who create apps using Ethereum’s programming language (Solidity) can now run their apps directly on Injective without needing complicated connections between blockchains. Transactions are fast (about 0.64 seconds per block) and very cheap (around $0.00008 per transaction). Over 40 projects, including lending and trading platforms, launched right away.

Why it matters:
This upgrade is positive for INJ because it brings together Ethereum’s large developer community with Cosmos’ ability to connect different blockchains. This could lead to more decentralized finance (DeFi) activity on Injective. Also, a new token standard called MultiVM helps reduce liquidity fragmentation, making it easier to use capital efficiently. (Crypto.News)

2. Binance Rewards Campaign (November 12, 2025)

What happened:
Binance Square started a month-long campaign giving away 11,760 INJ tokens (about $88,000) to users who trade at least $10 worth of INJ or create content about it. The top 100 content creators will share 70% of the rewards, encouraging more community involvement.

Why it matters:
This campaign could temporarily boost trading volume and social interest in INJ. However, the token’s price has dropped 42% over the past 60 days, showing some market caution. How many people join the campaign will help show if retail investors are still interested. (Binance)

3. Price Approaching $10 (November 11, 2025)

What happened:
INJ’s price rose 17% over the week to $7.49 (as of November 13). Analysts see signs it might break out of a downward price pattern. The next resistance levels are between $8.50 and $9. If the price falls below $7, it could drop further to around $6.30, a low from June.

Why it matters:
The price action looks cautiously optimistic, but INJ’s fundamentals—like a 50% drop over 90 days and relatively low total value locked (TVL) in DeFi at $38 million—don’t fully support a strong rally yet. A clear move above $9.50 might indicate a real trend change.

Conclusion

Injective’s new EVM feature and Binance’s rewards campaign aim to bring more developers and traders to the platform. Still, INJ’s future depends on real-world use, like how many people use its apps and how much value is locked in its DeFi projects. The big question: Can the influx of Ethereum developers overcome broader market challenges that have been holding INJ’s price down?


What is expected in the development of INJ?

Injective’s roadmap is centered on growing its decentralized finance (DeFi) infrastructure, improving how different blockchains work together, and increasing adoption by institutional investors.

  1. EVM Mainnet Launch (Q4 2025) – Making Injective fully compatible with Ethereum to allow easy migration of decentralized apps (dApps).
  2. iBuild Platform Rollout (2026) – An AI-powered, no-code tool that lets anyone create decentralized apps without programming skills.
  3. Community Burn Enhancements (Ongoing) – Monthly token burn auctions designed to reduce the supply of INJ and support its value.
  4. MultiVM Integration (2026) – Support for multiple blockchain environments like Solana, Ethereum, and Cosmos to enable cross-chain applications.

Deep Dive

1. EVM Mainnet Launch (Q4 2025)

Overview: The upcoming Ethernia upgrade will add Ethereum Virtual Machine (EVM) compatibility to Injective. This means developers can build and run Ethereum-based apps using Solidity programming language while still benefiting from Injective’s connection to the Cosmos ecosystem. The public testnet is already live, with the full launch expected by late 2025 (CoinDesk).

What this means:

2. iBuild Platform Rollout (2026)

Overview: iBuild is a user-friendly platform that uses artificial intelligence to let people create DeFi apps through simple language commands—no coding required. A live demo at the Injective Summit 2025 showed how quickly a prototype can be turned into a live app (MDCryptoWorld).

What this means:

3. Community Burn Enhancements (Ongoing)

Overview: Injective is shifting from weekly to monthly token burn auctions. These auctions limit how much each participant can contribute and use smart contracts to manage the burns automatically. So far, over 6.6 million INJ tokens (worth about $31 million) have been permanently removed from circulation (Blockworks).

What this means:

4. MultiVM Integration (2026)

Overview: MultiVM will let developers deploy apps across different blockchain virtual machines—Ethereum, Solana, and Cosmos—without rewriting code. The testnet already supports liquidity pools that work across these environments, with a full launch planned for 2026.

What this means:

Conclusion

Injective’s roadmap combines technical upgrades (EVM and MultiVM support) with tools to grow its community and ecosystem (iBuild and token burns). Backed by a $150 million venture fund and upcoming ETF filings (such as with 21Shares), Injective is gaining interest from institutional players. Still, challenges remain if the overall crypto market stays slow.

Will Injective’s EVM integration help it outpace competitors in attracting Ethereum-based projects?


What updates are there in the INJ code base?

Injective recently updated its technology with new deflationary features and added support for Ethereum-compatible applications.

  1. INJ 3.0 Tokenomics (July 2025) – Faster token burning linked to staking activity.
  2. Ethereum VM Integration (November 11, 2025) – Built-in support for Ethereum-based decentralized apps (dApps).
  3. Canonical Chain Upgrade (July 2025) – Important update for network validators and node operators.

Deep Dive

1. INJ 3.0 Tokenomics (July 2025)

Overview:
The INJ 3.0 update increases the rate at which tokens are burned (taken out of circulation) by 400%, adjusting automatically based on how many tokens are staked. This helps reduce the total supply of INJ over time, making the tokens more scarce.

What this means:
This is good news for INJ holders because more staking means more tokens are burned, which can increase the value of remaining tokens. It also encourages people to hold and stake their tokens, which helps keep the network secure.
(Source)

2. Ethereum VM Integration (November 11, 2025)

Overview:
Injective has added a native Ethereum Virtual Machine (EVM) to its blockchain. This means developers can now run Ethereum-compatible smart contracts (written in Solidity) directly on Injective without needing extra tools or bridges.

What this means:
This expands the number of developers who can build on Injective and connects liquidity between the Cosmos and Ethereum ecosystems. Users benefit from faster transaction finality (under a second) and very low fees.
(Source)

3. Canonical Chain Upgrade (July 2025)

Overview:
This mandatory upgrade required validators (the network’s transaction verifiers) to update their software to a new version (injectived v10006-rc1). Node operators had to update and restart their systems to keep the network running smoothly.

What this means:
This update is neutral for INJ holders—it mainly improves the network’s stability and reliability. Validators who delayed the update risked temporary downtime but helped ensure the network’s long-term health.
(Source)

Conclusion

Injective’s recent upgrades focus on reducing token supply through staking-driven burns, improving cross-chain compatibility, and strengthening network infrastructure. The Ethereum VM integration makes Injective a strong platform for multi-chain decentralized finance (DeFi), while the INJ 3.0 tokenomics could increase token scarcity. It will be interesting to see how developer interest in Injective’s MultiVM environment affects its position in the DeFi market.


Why did the price of INJ fall?

Injective (INJ) dropped 4.6% in the last 24 hours to $7.43, underperforming the overall crypto market, which fell by 0.95%. The main reasons for this decline are:

  1. Profit-taking after EVM launch – Investors sold off some of their holdings following the rollout of Injective’s native Ethereum Virtual Machine (EVM), despite the technical improvements.
  2. Binance network upgrade – Temporary pauses on deposits and withdrawals reduced trading activity and liquidity.
  3. Bearish technical signals – The price is trading below important moving averages and key price levels, indicating downward pressure.

Deep Dive

1. Profit-Taking After the Upgrade (Negative Impact)

Overview:
On November 11, Injective launched its native Ethereum Virtual Machine (EVM), which allows developers to build smart contracts compatible with Ethereum. This upgrade attracted over 40 new decentralized applications (dApps). However, the price dropped 8% after the announcement, showing a typical “buy the rumor, sell the news” pattern (Crypto.News).

What this means:

Key point to watch: Whether the adoption of the EVM leads to sustained growth in total value locked (TVL), which currently stands at $28.6 million, to balance out the selling pressure.

2. Weak Technical Setup (Negative Impact)

Overview:
INJ’s price fell below its 30-day simple moving average (SMA) of $8.02 and a key pivot point at $7.44. The Relative Strength Index (RSI) is at 41.6, indicating a neutral to slightly bearish outlook. The Moving Average Convergence Divergence (MACD) shows weak momentum, and the longer-term 200-day SMA is at $11.92, well above the current price.

What this means:

3. Overall Market Caution (Mixed Impact)

Overview:
The crypto market’s fear/greed index is at 25, signaling “Fear,” and Bitcoin’s dominance has increased to 59.08%. This means investors are favoring Bitcoin over alternative coins like INJ.

What this means:

Conclusion

Injective’s recent price drop is mainly due to profit-taking after its major EVM upgrade, weak technical indicators, and cautious sentiment across the crypto market. While the EVM launch improves Injective’s long-term potential, it’s important for the price to hold above $7.00 and reclaim $8.00 to reverse the current downward trend. Key watch: How INJ performs as Binance restores normal liquidity following its network upgrade.